Status:
ACTIVE_NOT_RECRUITING
Cohort Of DEafness-gene Screening
Lead Sponsor:
Affiliated Hospital of Nantong University
Collaborating Sponsors:
Nantong Maternal and Child Health Care Hospital
Conditions:
Hearing Loss
Eligibility:
All Genders
3-1 years
Brief Summary
This study was based on a concurrent newborn genetic and hearing screening program in Nantong city. From January 2016 to December 2020, newborn infants were recruited and received combined screening f...
Detailed Description
The severity of hearing loss was graded as mild (26-40 dB), moderate (41-60 dB), severe (61-80 dB), and profound (≥81 dB). Genomic DNA was extracted by a blood filter paper nucleic acid extraction ki...
Eligibility Criteria
Inclusion
- The infants were born between January 2016 and December 2020;
- The infants' health condition was good enough to tolerate the screening procedures;
- The parents were urban residents of Nantong city;
- The parents agreed to have their babies participating in the combined hearing and genetic screening program.
Exclusion
- The infants' blood samples were unqualified for the genetic tests according to criteria of the National Health Commission of China's technical specification for neonatal screening of congenital diseases;
- The infants were lost to follow-up.
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2028
Estimated Enrollment :
35920 Patients enrolled
Trial Details
Trial ID
NCT06133946
Start Date
January 1 2016
End Date
December 31 2028
Last Update
November 18 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.